EURASIAN JOURNAL OF PULMONOLOGY, cilt.19, sa.2, ss.84-90, 2017 (ESCI)
Objective: The mechanism of biological treatment molecule called omalizumab used in asthma treatment is thought to be versatile; however, the mechanism still remains unknown. This study was undertaken in severe asthma patients underwent omalizumab treatment, in order to investigate the relationship between biomarker expression and disease characteristics related to the immune system.